ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 22032040 0 FOR 22032040 FOR ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22032040 0 1 YEAR 22032040 FOR ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3457815 0 FOR 3457815 FOR BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 CARDIFF ONCOLOGY, INC. 14147L108 US14147L1089 06/11/2026 Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2411575 0 FOR 2411575 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ESSA PHARMA INC. 29668H708 CA29668H7085 10/03/2025 To consider, and, if thought advisable, to pass, an ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to its named executive officers that is based on or otherwise relates to the Arrangement, all as more particularly described in the Circular and Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1675000 0 FOR 1675000 FOR GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2928 0 FOR 2928 FOR NEXTCURE, INC. 65343E207 US65343E2072 06/18/2026 Approval, on an advisory basis, of the compensation paid by Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 75847 0 FOR 75847 FOR ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3656440 0 FOR 3656440 FOR ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3656440 0 1 YEAR 3656440 FOR Q32 BIO INC. 746964105 US7469641051 06/12/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 74766 0 FOR 74766 FOR SENSEONICS HOLDINGS, INC. 81727U303 US81727U3032 05/20/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 SENSEONICS HOLDINGS, INC. 81727U303 US81727U3032 05/20/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 SPERO THERAPEUTICS, INC. 84833T103 US84833T1034 06/23/2026 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2362348 0 FOR 2362348 FOR WAVE LIFE SCIENCES LTD. Y95308105 SG9999014716 08/05/2025 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 WAVE LIFE SCIENCES LTD. Y95308105 SG9999014716 08/05/2025 To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ZENTALIS PHARMACEUTICALS, INC. 98943L107 US98943L1070 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 953834 0 FOR 953834 FOR